November 16, 2022 News by Somi Igbene, PhD Treatments Seen to Account for Largest Part of MS Financial Burden Medications account for the majority of costs related to managing multiple sclerosis (MS) in Italy, and secondary-progressive MS (SPMS) is associated with higher treatment and healthcare costs than those for relapsing-remitting multiple sclerosis (RRMS), a study looking at real-world data reported. “A bigger healthcare resource consumption was retrieved for…
March 9, 2022 News by Somi Igbene, PhD Ketogenic Diet Eases Symptoms, Aids Life Quality in Small RRMS Study A short-term ketogenic diet, which dramatically cuts carbohydrate consumption, is safe and results in significant improvements in people with relapsing-remitting multiple sclerosis (RRMS), a small study in patients reported. “Our study provides evidence that a ketogenic diet is safe and beneficial, reducing some symptoms for people with MS, when…
December 14, 2021 News by Somi Igbene, PhD Regular Eye Screening Vital for MS Patients, Study Finds Visual disturbances are common in people with multiple sclerosis (MS), particularly among those with secondary progressive MS (SPMS), longer disease duration, and worse disability status, a new study has found. Yet, “visual complaints may occur in people with all types of MS, anytime along the disease course, and…
November 17, 2021 News by Somi Igbene, PhD Long-term Supplement Use May Improve Gait, Strength in RRMS Long-term use of a high-dose nutritional supplement containing specific antioxidant vitamins and omega-3 and omega-6 fatty acids may boost walking performance and other measures of functional capacity in people with relapsing-remitting multiple sclerosis (RRMS), a new study found. The study, “The Effects of Specific Omega-3 and…
November 15, 2021 News by Somi Igbene, PhD Longer Breastfeeding May Damage Brain By Delaying DMT Use Having at least one pregnancy may lower disability scores in women with multiple sclerosis (MS), but breastfeeding for longer than six months may worsen damage to the brain, an observational study in patients has found. Findings support the need for careful pregnancy planning, counseling, and treatment management to ensure…
November 3, 2021 News by Somi Igbene, PhD No Link Found Between Vitamin D Levels, Age at First MS Symptoms There is no link between serum vitamin D levels and the age at which an individual develops the first symptoms of multiple sclerosis (MS), a new observational study suggests. However, a link was found between cerebrospinal fluid antibody levels, serum vitamin D levels, and the age at first MS…
October 22, 2021 News by Somi Igbene, PhD Brain Volume, NfL Level Changes May Predict Disability in Relapsing MS A model that considers changes in brain volume and serum neurofilament (sNfL) levels during the early stages of multiple sclerosis may help clinicians to determine an individual’s likely progression with relapsing forms of MS, a study suggests. “We were able to build reliable, robust models capable of accurate predictions of…
October 5, 2021 News by Somi Igbene, PhD COVID-19 Stalling MS Research Into Rehabilitation, Quality of Life The COVID-19 pandemic appears to be stalling research into rehabilitation and quality of life (QoL) for people with multiple sclerosis (MS) in many countries worldwide, a new observational study reports. According to the study, many researchers have found it “significantly more” challenging to recruit participants for studies, and most…
September 24, 2021 News by Somi Igbene, PhD Mount Sinai MS Experts Earn Hope Award The National Multiple Sclerosis Society has granted its 2021 Hope Award to two multiple sclerosis (MS) experts at Mount Sinai Health System for their clinical ingenuity and significant research contributions that have uplifted individuals, families and communities affected with the chronic condition. Aaron Miller, MD, professor of neurology…
September 22, 2021 News by Somi Igbene, PhD Stopping Fingolimod – Gilenya – for Pregnancy Raises Relapse Risk Women with relapsing-remitting multiple sclerosis (MS) who suspend their use of fingolimod — sold as Gilenya, among others — to conceive or during the early stages of pregnancy have a significantly higher risk of relapse during and after pregnancy, a new study finds. Stopping fingolimod resulted in a…
September 13, 2021 News by Somi Igbene, PhD Health Status of Immigrants With MS Complex, Canadian Study Finds A number of health conditions — including high blood pressure, migraines, schizophrenia, and rheumatoid arthritis — are more common among immigrants to Canada who have multiple sclerosis (MS) than those without MS, an observational study reported. Compared with long-term residents with MS, immigrants with this disease were less likely to…
September 2, 2021 News by Somi Igbene, PhD FDA to Review ANI’s Request for Cortrophin Gel Use The U.S. Food and Drug Administration (FDA) has agreed to review ANI Pharmaceuticals’ supplemental new drug application for the approval of Cortrophin Gel to treat people with multiple sclerosis (MS) and other chronic inflammatory conditions, including rheumatoid arthritis. Purified Cortrophin Gel (repository corticotropin injection USP) is a purified…
August 26, 2021 News by Somi Igbene, PhD Pain, Fatigue, Anxiety Common in First Year After CIS/MS Diagnosis People newly diagnosed with clinically isolated syndrome (CIS) or multiple sclerosis (MS) frequently experience pain, fatigue, depression, and anxiety in the first year after diagnosis, a new study finds. Fatigue was reported by almost two-thirds of new patients, and half experienced pain. Many individuals experienced multiple symptoms simultaneously,…
August 25, 2021 News by Somi Igbene, PhD Ocrevus Reduces MS Relapse Risk, But Linked to More Hospitalizations Ocrevus (ocrelizumab) reduces relapse risk and slows disability progression in multiple sclerosis (MS) but also is associated with higher hospitalization rates in older people with relapsing forms of the disease, a new observational study reports. Hospitalizations — which occurred mainly due to urinary tract infections — were more frequent…
July 30, 2021 News by Somi Igbene, PhD ‘Burgers to Beat MS’ Fundraiser Opens Across Canada on Aug. 19 “Burgers to Beat MS,” A&W Canada‘s annual fundraiser to support the MS Society of Canada and people with multiple sclerosis (MS), returns for its 13th year on Thursday, Aug. 19, aiming to raise over $1.5 million. Canada has one of the highest MS rates globally, with more than 90,000…
July 23, 2021 News by Somi Igbene, PhD Hypertension Triples Disability Risk in Hispanic/Latino MS Patients Hypertension — high blood pressure — triples the risk of severe walking disability in Hispanic and Latino people with multiple sclerosis (MS), a new observational study reports. The study, “Hypertension and hypertension severity in Hispanics/Latinx with MS,” was published in the Multiple Sclerosis Journal. Although…
July 22, 2021 News by Somi Igbene, PhD Multivitamins Reduce Fatigue, Improving Quality of Life Multivitamin supplements reduce fatigue and improve quality of life in people with relapsing-remitting multiple sclerosis (RRMS), a new study reports. After 70 days of continuous use, patients taking multivitamin supplements containing vitamins A, B-complex, C, and D improved their blood antioxidant status and experienced up to a 34% reduction…
July 20, 2021 News by Somi Igbene, PhD Strength of Exhalations May Predict Physical Ability, MS Severity The strength of the muscles used to exhale a breath may predict physical ability and disease severity in people with multiple sclerosis (MS), a study reported. Patients in this study with weaker expiratory muscles were also those with greater physical disability and more severe disease. The study, “Pulmonary…
July 16, 2021 News by Somi Igbene, PhD Isoflavone-rich Diet Boosts Gut Health, Lessening MS Severity Isoflavone-rich diets boost gut health and lessen multiple sclerosis (MS) severity, a new study in mice suggests. In the study, mice with MS that were fed a diet rich in isoflavone — a plant-based compound — developed diverse and abundant gut bacteria, particularly isoflavone-digesting bacteria, which produced compounds that…
July 13, 2021 News by Somi Igbene, PhD Patients Less Likely to Stop Taking Tecfidera Than Aubagio: Study Tecfidera has a lower risk of discontinuation due to treatment failure than Aubagio in people with multiple sclerosis (MS), a new observational study in Norway suggests. In the study, people receiving Tecfidera (dimethyl fumarate) were 38% less likely to experience treatment failure and stop use than those receiving…
July 1, 2021 News by Somi Igbene, PhD Familial MS Most Common in Children, Women, Warmer Climates Inherited or familial multiple sclerosis (MS) occurs most frequently in children, women, and people living in warmer climates, a new study suggests. Prevalence rates also differ according to geographical areas, with Canada exhibiting the highest rates and Hungary the lowest. The study, “The global prevalence of familial multiple sclerosis:…
June 30, 2021 News by Somi Igbene, PhD Sleep Deprivation May Worsen Memory in Early MS Sleep deprivation may worsen memory in people with clinically isolated syndrome (CIS) or relapsing-remitting multiple sclerosis (RRMS), a new observational study suggests. A link also was observed between a lack of sleep and worse cognitive efficiency in early MS, but that association was caused by the worse moods…
June 25, 2021 News by Somi Igbene, PhD Raised Serum NfL Levels May Indicate Chronic Active Lesions Raised serum neurofilament light chain (sNfL) levels may indicate the presence of brain lesions with chronically active inflammation that are linked with more aggressive forms of multiple sclerosis (MS), a new study suggests. People with high sNfL levels, the study revealed, had greater numbers of chronic inflammation lesions and…
June 24, 2021 News by Somi Igbene, PhD MIND Diet May Protect Brain Tissue in MS A higher adherence to the MIND diet – short for Mediterranean-Dietary Approach to Stop Hypertension Intervention (DASH) for Neurodegenerative Delay – may protect brain tissue from further damage in people with multiple sclerosis (MS), new research suggests. In particular, consuming more high-fat dairy products was associated with a lower…
June 23, 2021 News by Somi Igbene, PhD High Free Light Chains Levels May Indicate Sooner Second Relapse High levels of kappa-free light chains, or kappa-FLC, in the cerebrospinal fluid (CSF) — the liquid surrounding the brain and spinal cord — may help identify people with clinically isolated syndrome (CIS) who will progress sooner to multiple sclerosis (MS), a study reports. Overall, those with a high…
June 18, 2021 News by Somi Igbene, PhD Younger Age, DMT Use at Early Relapse May Lessen Later Disability People with multiple sclerosis (MS) who are using a disease-modifying therapy — and are at a younger age — when they have a relapse within the first three years of their disease course are more likely to recover completely, lowering their risk of long-term, 10-year disability, a study suggests. Complete recovery…
June 17, 2021 News by Somi Igbene, PhD MS Does Not Raise Woman’s Risk of Child With Brain Disorder, Study Suggests Children born to women with multiple sclerosis (MS) are not at a higher risk of brain disorders than are children whose mothers don’t have this disease, an observational study reported. However, children born to women with a family with a history of other autoimmune conditions and brain disorders, or…